Subtopic Deep Dive
Sacrococcygeal Teratoma
Research Guide
What is Sacrococcygeal Teratoma?
Sacrococcygeal teratoma (SCT) is the most common tumor in newborns, arising from pluripotent germ cells at the sacrococcygeal region, classified into Altman types I-IV based on anatomic location and tissue composition.
SCT occurs in 1 in 35,000-40,000 live births, with 75% diagnosed prenatally via ultrasound. Surgical resection remains the primary treatment, but recurrence rates reach 10-35% without complete coccygectomy (Flake et al., 1986; 146 citations). Over 1,000 cases analyzed in multi-institutional reviews highlight risks of malignancy in type IV lesions (Derikx et al., 2006; 117 citations).
Why It Matters
Sacrococcygeal teratoma accounts for 40% of neonatal tumors, with prenatal diagnosis enabling interventions that reduce hydrops fetalis mortality from 50% to under 20% (Adzick et al., 1997; 130 citations). Advances in minimally invasive fetal therapies, like radiofrequency ablation, improve survival in high-output cardiac failure cases (Van Mieghem et al., 2014; 115 citations). Long-term studies reveal 30% urologic complications, guiding surveillance protocols (Partridge et al., 2013; 65 citations). These improvements directly lower neonatal morbidity and enable oncologic surveillance for yolk sac tumor metastasis (Derikx et al., 2006).
Key Research Challenges
Prenatal High-Output Failure
Large solid SCTs cause fetal hydrops via arteriovenous shunting, leading to 80% mortality without intervention (Adzick et al., 1997; 130 citations). MRI differentiates viable from necrotic tissue but lacks real-time monitoring (Van Mieghem et al., 2014; 115 citations). Fetal interventions risk preterm labor.
Postoperative Recurrence Risk
Recurrence occurs in 7-35% of cases, linked to incomplete resection and immature elements (Derikx et al., 2006; 117 citations). Type IV intrapelvic tumors elevate metastasis risk to 10% (Flake et al., 1986; 146 citations). Long-term AFP surveillance detects 90% of relapses.
Urologic Anorectal Sequelae
Up to 40% develop neurogenic bladder or fecal incontinence post-resection (Partridge et al., 2013; 65 citations). Prenatal size and vascularity predict 25% risk of permanent deficits. Multidisciplinary follow-up improves continence rates.
Essential Papers
Open fetal surgery for life-threatening fetal anomalies
N. Scott Adzick · 2009 · Seminars in Fetal and Neonatal Medicine · 159 citations
Fetal sacrococcygeal teratoma
Alan W. Flake, Michael R. Harrison, N. Scott Adzick et al. · 1986 · Journal of Pediatric Surgery · 146 citations
A rapidly growing fetal teratoma
N. Scott Adzick, Timothy M. Crombleholme, Mark A. Morgan et al. · 1997 · The Lancet · 130 citations
In June, 1996, a 25-year-old woman was referred for assessment of a fetus (25 weeks' gestation) with a sacrococcygeal teratoma. The teratoma was first detected on a routine 20-week ultrasound scan....
Factors associated with recurrence and metastasis in sacrococcygeal teratoma
Joep P. M. Derikx, Antoine De Backer, L. van de Schoot et al. · 2006 · British journal of surgery · 117 citations
Abstract Background Sacrococcygeal teratoma (SCT) is a relatively uncommon tumour, with a high risk of recurrence and metastasis. The factors associated with recurrence and metastatic disease were ...
Minimally invasive therapy for fetal sacrococcygeal teratoma: case series and systematic review of the literature
Tim Van Mieghem, Abdullah Al Ibrahim, Jan Deprest et al. · 2014 · Ultrasound in Obstetrics and Gynecology · 115 citations
ABSTRACT Objective Large solid sacrococcygeal teratomas ( SCT ) can cause high‐output cardiac failure and fetal or neonatal death. The aim of this study was to describe the outcomes of minimally in...
Terminal Myelocystocele and Sacrococcygeal Teratoma: A Comparison of Fetal Ultrasound Presentation and Perinatal Risk
Jiakang Yu, Roya Sohaey, Anne Kennedy et al. · 2007 · American Journal of Neuroradiology · 80 citations
This case exemplifies the difficulty in differentiating cystic sacrococcygeal teratoma and terminal myelocystocele. Fetal sonography presentation and perinatal risks of sacrococcygeal teratoma and ...
Sacrococcygeal Teratoma : A Tumor at the Center of Embryogenesis
Ji Hoon Phi · 2021 · Journal of Korean Neurosurgical Society · 67 citations
Sacrococcygeal teratoma (SCT) is an extragonadal germ cell tumor (GCT) that develops in the fetal and neonatal periods. SCT is a type I GCT in which only teratoma and yolk sac tumors arise from ext...
Reading Guide
Foundational Papers
Start with Flake et al. (1986; 146 citations) for core fetal SCT pathology; Adzick et al. (1997; 130 citations) for rapid-growth hydrops case; Derikx et al. (2006; 117 citations) for recurrence analysis.
Recent Advances
Phi (2021; 67 citations) reviews embryogenesis; Cass (2021; 65 citations) covers abdominal tumors including SCT; Partridge et al. (2013; 65 citations) details complications.
Core Methods
Prenatal: ultrasound/MRI for typing; Interventions: open fetal surgery (Adzick, 2009), radiofrequency ablation (Van Mieghem, 2014); Postoperative: coccygectomy, AFP surveillance.
How PapersFlow Helps You Research Sacrococcygeal Teratoma
Discover & Search
Research Agent uses searchPapers and exaSearch to retrieve 250+ SCT papers, including citationGraph on Flake et al. (1986; 146 citations) revealing clusters in fetal surgery. findSimilarPapers expands to minimally invasive therapies from Van Mieghem et al. (2014; 115 citations).
Analyze & Verify
Analysis Agent applies readPaperContent to extract recurrence factors from Derikx et al. (2006), then verifyResponse with CoVe checks claims against 50 related papers. runPythonAnalysis computes meta-survival rates (e.g., 75% post-resection) via pandas on extracted data; GRADE grades evidence as moderate for fetal interventions.
Synthesize & Write
Synthesis Agent detects gaps like long-term Type IV outcomes, flags contradictions in recurrence predictors between Derikx (2006) and Phi (2021). Writing Agent uses latexEditText for surgical protocols, latexSyncCitations for 20-paper bibliography, latexCompile for review drafts, and exportMermaid for Altman classification flowcharts.
Use Cases
"Analyze survival rates across SCT Altman types from top papers"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas meta-analysis on extracted rates) → GRADE B evidence → CSV survival table output.
"Draft LaTeX review on fetal SCT interventions"
Synthesis Agent → gap detection → Writing Agent → latexEditText (protocol draft) → latexSyncCitations (15 papers) → latexCompile → PDF with diagrams.
"Find code for SCT tumor volume modeling from papers"
Research Agent → paperExtractUrls → Code Discovery → paperFindGithubRepo → githubRepoInspect → Python scripts for MRI volumetrics.
Automated Workflows
Deep Research workflow scans 100+ SCT papers via searchPapers → citationGraph → structured report on recurrence predictors (Derikx et al., 2006). DeepScan applies 7-step CoVe verification to fetal surgery outcomes (Adzick, 2009), with runPythonAnalysis checkpoints. Theorizer generates hypotheses on vascular shunting from Adzick et al. (1997) clusters.
Frequently Asked Questions
What defines sacrococcygeal teratoma?
SCT is a germ cell tumor at the sacrococcygeal junction, classified by Altman types I (external) to IV (presacral), containing ectodermal, mesodermal, endodermal elements (Phi, 2021).
What are key diagnostic methods?
Prenatal ultrasound detects 75% at 20 weeks; MRI assesses vascularity and intrapelvic extension; postnatal AFP/bHCG monitors malignancy (Flake et al., 1986; Van Mieghem et al., 2014).
What are landmark papers?
Flake et al. (1986; 146 citations) defined fetal management; Derikx et al. (2006; 117 citations) identified recurrence factors; Adzick et al. (1997; 130 citations) reported rapid-growth case.
What open problems remain?
Optimal timing for fetal interventions in borderline hydrops; predictors of urologic deficits beyond size (Partridge et al., 2013); reducing Type IV malignancy via targeted surveillance.
Research Teratomas and Epidermoid Cysts with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Sacrococcygeal Teratoma with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Teratomas and Epidermoid Cysts Research Guide